Sign in
4

Changes in Ownership

Taysha Gene Therapies, Inc. Filed Acc 0001209191-21-033009

Director bought 12,000 shares at $20.98 ($251,760)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Manning Paul B Director 2021-05-14 Purchase +12,000 $20.98 $251,760 12,000 D
Open-market purchases · 12,000 sh · avg $20.98 · $251,760
Loading xslF345X03/doc4.xml…